These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1526246)

  • 1. Antimicrobial susceptibility and serotyping of Chlamydia trachomatis strains isolated before and after treatment with ciprofloxacin and doxycycline.
    van der Willigen AH; van Rijsoord-Vos T; Wagenvoort JH; Stamm WE; Suchland RJ; Stolz E
    Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):561-3. PubMed ID: 1526246
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.
    Segreti J; Kessler HA; Kapell K; Trenholme GM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):87S-88S. PubMed ID: 2791503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
    Agacfidan A; Moncada J; Schachter J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
    Segreti J; Kessler HA; Kapell KS; Trenholme GM
    Antimicrob Agents Chemother; 1987 Jan; 31(1):100-1. PubMed ID: 2952061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.
    Segreti J; Kessler HA; Kapell KS; Trenholme GM
    Antimicrob Agents Chemother; 1989 Jan; 33(1):118-9. PubMed ID: 2712543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
    Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
    Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
    Bai H; Dong J; Ning B
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
    Donati M; Di Francesco A; D'Antuono A; Delucca F; Shurdhi A; Moroni A; Baldelli R; Cevenini R
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5379-80. PubMed ID: 20855744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
    Foschi C; Salvo M; Cevenini R; Marangoni A
    J Antimicrob Chemother; 2018 Feb; 73(2):409-413. PubMed ID: 29077843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
    Madhavan HN; Roy S; Malathy J
    Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of fifteen Chlamydia trachomatis strains isolated in Greece.
    Mentis AF; Tzouvelekis LS; Mavrommati L
    J Antimicrob Chemother; 1989 Jul; 24(1):94. PubMed ID: 2777733
    [No Abstract]   [Full Text] [Related]  

  • 15. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
    Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M
    J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].
    Cao W; Liu L; Tong MH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):177-9. PubMed ID: 12934372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Chlamydia trachomatis to trovafloxacin.
    Jones RB; Van der Pol B; Johnson RB
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():63-5. PubMed ID: 9222072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.